These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 32207276)

  • 1. Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service.
    Kim JH; Moon H; Noh J; Lee J; Kim SG
    Endocrinol Metab (Seoul); 2020 Mar; 35(1):157-164. PubMed ID: 32207276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas.
    Kim KY; Kim JH; Hong AR; Seong MW; Lee KE; Kim SJ; Kim SW; Shin CS; Kim SY
    PLoS One; 2016; 11(12):e0168413. PubMed ID: 27992508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas.
    Pamporaki C; Hamplova B; Peitzsch M; Prejbisz A; Beuschlein F; Timmers HJLM; Fassnacht M; Klink B; Lodish M; Stratakis CA; Huebner A; Fliedner S; Robledo M; Sinnott RO; Januszewicz A; Pacak K; Eisenhofer G
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1122-1132. PubMed ID: 28324046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY.
    Turkova H; Prodanov T; Maly M; Martucci V; Adams K; Widimsky J; Chen CC; Ling A; Kebebew E; Stratakis CA; Fojo T; Pacak K
    Endocr Pract; 2016 Mar; 22(3):302-14. PubMed ID: 26523625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metastatic risk factors in pheochromocytoma/paraganglioma].
    Rebrova DV; Loginova OI; Vorobyev SL; Vorokhobina NV; Kozorezova ES; Indeykin FA; Savelyeva TV; Sleptsov IV; Chernikov RA; Fedorov EA; Semenov AA; Chinchuk IK; Shikhmagomedov SS; Alekseev MA; Krasnov LM; Rusakov VF
    Probl Endokrinol (Mosk); 2023 Oct; 70(2):37-45. PubMed ID: 38796759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pheochromocytoma and paraganglioma: An emerging cause of secondary osteoporosis.
    Yokomoto-Umakoshi M; Umakoshi H; Fukumoto T; Matsuda Y; Nagata H; Ogata M; Kawate H; Miyazawa T; Sakamoto R; Ogawa Y;
    Bone; 2020 Apr; 133():115221. PubMed ID: 31940499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas.
    Ruff SM; Ayabe RI; Malekzadeh P; Good ML; Wach MM; Gonzales MK; Tirosh A; Nilubol N; Pacak K; Kebebew E; Patel D
    J Surg Res; 2019 Nov; 243():1-7. PubMed ID: 31146085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center.
    Pham TH; Moir C; Thompson GB; Zarroug AE; Hamner CE; Farley D; van Heerden J; Lteif AN; Young WF
    Pediatrics; 2006 Sep; 118(3):1109-17. PubMed ID: 16951005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas.
    Al-Harthy M; Al-Harthy S; Al-Otieschan A; Velagapudi S; Alzahrani AS
    Endocr Pract; 2009 Apr; 15(3):194-202. PubMed ID: 19364686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical differences between small and large pheochromocytomas and paragangliomas.
    Zhao L; Li Z; Meng X; Fan H; Zhang Z; Zhang Z; Liu Y; Zhou X; Zhu H
    Front Endocrinol (Lausanne); 2023; 14():1087506. PubMed ID: 36967797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas.
    Araujo-Castro M; Mínguez Ojeda C; García Centeno R; López-García MC; Lamas C; Hanzu FA; Mora M; Del Castillo Tous M; Rodríguez de Vera Gómez P; Parra Ramírez P; Alvarez-Escola C; Blanco Carrera C; Barahona San Millán R; Recasens M; Valdés N; Gracia Gimeno P; de Miguel Novoa P; Vicente A; Manjón L; García Sanz I; Michalopoulou T; Calatayud M
    Endocr Relat Cancer; 2022 Dec; 29(12):645-655. PubMed ID: 36069783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute cardiac complications and subclinical myocardial injuries associated with pheochromocytoma and paraganglioma.
    Zhou J; Xuan H; Miao Y; Hu J; Dai Y
    BMC Cardiovasc Disord; 2021 Apr; 21(1):203. PubMed ID: 33882857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical profiles of patients with surgically resected pheochromocytoma and paraganglioma.
    Lee SH; Park JH; Lee JY; Lee SR; Rhee KS; Chae JK; Kim WH; Sul JY; Oh JK; Kwon HJ; Lee JH; Seong IW
    Korean J Intern Med; 2020 Mar; 35(2):351-359. PubMed ID: 30808127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience.
    De Filpo G; Cantini G; Rastrelli G; Vannini G; Ercolino T; Luconi M; Mannelli M; Maggi M; Canu L
    J Endocrinol Invest; 2022 Jan; 45(1):149-157. PubMed ID: 34227051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pheochromocytoma and Paraganglioma Patients With Poor Survival Often Show Brown Adipose Tissue Activation.
    Abdul Sater Z; Jha A; Hamimi A; Mandl A; Hartley IR; Gubbi S; Patel M; Gonzales M; Taïeb D; Civelek AC; Gharib AM; Auh S; O'Mara AE; Pacak K; Cypess AM
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1176-85. PubMed ID: 31903484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic instability during percutaneous ablation of extra-adrenal metastases of pheochromocytoma and paragangliomas: a case series.
    Deljou A; Kohlenberg JD; Weingarten TN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
    BMC Anesthesiol; 2018 Nov; 18(1):158. PubMed ID: 30400849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in intraoperative and surgical outcomes between normotensive pheochromocytomas and sympathetic paragangliomas (PPGLs) and hypertensive PPGLs: results from the PHEO-RISK STUDY.
    Araujo-Castro M; García Sanz I; Mínguez Ojeda C; Calatayud M; Hanzu F; Mora M; Vicente A; Blanco Carrera C; De Miguel Novoa P; López García MDC; Manjón-Miguélez L; Rodríguez de Vera P; Del Castillo Tous M; Barahona San Millán R; Recasens M; Tomé Fernández-Ladreda M; Valdés N; Gracia Gimeno P; Robles Lazaro C; Michalopoulou T; Álvarez Escolá C; García Centeno R; Lamas C
    J Endocrinol Invest; 2023 Apr; 46(4):805-814. PubMed ID: 36323983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonselective Compared With Selective α-Blockade Is Associated With Less Intraoperative Hypertension in Patients With Pheochromocytomas and Paragangliomas: A Retrospective Cohort Study With Propensity Score Matching.
    Kong H; Li N; Yang XC; Nie XL; Tian J; Wang DX
    Anesth Analg; 2021 Jan; 132(1):140-149. PubMed ID: 32675634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force.
    Ku EJ; Kim KJ; Kim JH; Kim MK; Ahn CH; Lee KA; Lee SH; Lee YB; Park KH; Choi YM; Hong N; Hong AR; Kang SW; Park BK; Seong MW; Kim M; Jung KC; Jung CK; Cho YS; Paeng JC; Kim JH; Ryu OH; Rhee Y; Kim CH; Lee EJ
    Endocrinol Metab (Seoul); 2021 Apr; 36(2):322-338. PubMed ID: 33820394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years.
    Hamidi O; Young WF; Iñiguez-Ariza NM; Kittah NE; Gruber L; Bancos C; Tamhane S; Bancos I
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3296-3305. PubMed ID: 28605453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.